ArticleFrontiers in molecular neuroscience2024

C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repair.

Maria B Goncalves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.